Re: Disitamab Vedotin plus Toripalimab in HER2-Expressing Advanced Urothelial Cancer

European Urology 2026 Open access

Read full text

Authors: Giandomenico Roviello, Silvia Mancini, Lorenzo Antonuzzo

DOI: 10.1016/j.eururo.2026.01.006

Cited by: 0

References: 3

Fields of Study & Subjects

Bladder and Urothelial Cancer Treatments Cancer Immunotherapy and Biomarkers Lung Cancer Treatments and Mutations

References 3